Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.09.2020 | Case report

Cyclophosphamide/docetaxel/epirubicin

Myositis and lack of efficacy in invasive ductal breast carcinoma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Parida G, et al. Rare case of docetaxel-induced myositis detected on fluorodeoxyglucose positron emission tomography/computed tomography in a patient with carcinoma breast. Indian Journal of Nuclear Medicine 35: 248-250, No. 3, Sep 2020. Available from: URL: http://doi.org/10.4103/ijnm.IJNM_25_20 Parida G, et al. Rare case of docetaxel-induced myositis detected on fluorodeoxyglucose positron emission tomography/computed tomography in a patient with carcinoma breast. Indian Journal of Nuclear Medicine 35: 248-250, No. 3, Sep 2020. Available from: URL: http://​doi.​org/​10.​4103/​ijnm.​IJNM_​25_​20
Metadaten
Titel
Cyclophosphamide/docetaxel/epirubicin
Myositis and lack of efficacy in invasive ductal breast carcinoma: case report
Publikationsdatum
01.09.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-83460-y

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Erythromycin

Case report

Levamisole abuse

Case report

Acitretin